サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：リアルワールドエビデンスソリューション市場：コンポーネント別、治療分野別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1339896

リアルワールドエビデンスソリューション市場：コンポーネント別、治療分野別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Real World Evidence Solutions Market with COVID-19 Impact Analysis, By Component, By Therapeutic Areas, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
リアルワールドエビデンスソリューション市場：コンポーネント別、治療分野別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

リアルワールドエビデンスソリューション市場規模は2022年に24億810万米ドルとなり、2023年から2030年にかけてCAGR 8.4%で拡大

リアルワールドエビデンスソリューション市場-市場力学：

  • ヘルスケアにおけるエビデンスに基づく意思決定への需要の高まりが市場需要を促進。
  • 政策立案者、当局、医療専門家、製薬企業はいずれも、従来の臨床試験データだけに頼ることの限界を認識しており、治療法の実世界での有効性や長期的影響を完全に表しているとは限りません。RWEは、実世界の複雑さや違いを考慮しながら、様々な患者群における治療法の評価を可能にし、その結果、より良い情報に基づいたニュアンスのある結論をもたらします。さらに、価値ベースの医療と費用対効果への注目は、ヘルスケア治療の現実世界の結果と経済的結果に関する重要な情報を提供するため、RWEの需要を促進します。

リアルワールドエビデンスソリューション市場-セグメンテーション分析：

  • 世界のリアルワールドエビデンスソリューション市場は、コンポーネント、治療分野、エンドユーザー、地域に基づいてセグメント化されます。
  • 市場は、コンポーネントに基づいて2つのカテゴリに分かれています：データセット、コンサルティング、分析。コンサルティングと分析分野が市場を独占しています。リアルワールドエビデンス（RWE）ソリューションへのニーズの高まりにより、eコンサルティングと分析ソリューションへの需要が高まっています。これらのサービスは、利害関係者が実世界のヘルスケアデータにうまくアクセスし、解釈し、利用できるように支援します。これらのサービスにより、エビデンスに基づく意思決定、患者転帰の改善、洗練されたアナリティクスの採用による斬新なヘルスケアイニシアチブの創出が可能になります。
  • 市場は、治療領域に基づいて5つのカテゴリーに分類される：腫瘍学、心臓血管、神経学、免疫学、その他。オンコロジーは市場を独占しており、予測期間中もその優位性を維持するとみられます。様々ながん患者群における治療結果、安全性、有効性を理解する必要性から、がん領域におけるリアルワールドエビデンス（RWE）ソリューションの需要が高まっています。リアルワールドインサイトは臨床試験データを補完し、腫瘍学研究、薬物開発、個別化治療法を強化し、最終的にはがん治療を改善します。

リアルワールドエビデンスソリューション市場-地理的洞察：

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。アジア太平洋地域におけるReal World Evidence（RWE）ソリューションの需要の大幅な増加には、いくつかの理由が寄与しています。このように多様で膨大な人口を抱えるこの地域では、治療結果やヘルスケアイニシアチブの実世界での効果を理解することが急務となっています。RWEは、アジア太平洋地域のヘルスケアパートナーに、十分な知識を持った選択を行い、エビデンスに基づいた政策を実施し、医療資源をうまく最適化する力を与えます。さらに、この地域の多くの国々でデジタルヘルス技術と電子カルテの使用が拡大しているため、RWE調査のためのデータ収集が容易になっています。その結果、RWEソリューションはアジア太平洋全域で医療を拡大し、患者の成果を高めるために不可欠なものとなっています。

リアルワールドエビデンスソリューション市場-競合情勢：

医療におけるエビデンスに基づく意思決定の必要性が高まっているため、リアルワールドエビデンス（RWE）ソリューションの競合環境は急速に拡大しています。複数の企業や調査機関がこの市場に参入し、完全なRWEサービスを提供しています。これらの企業は、高度な分析、データ統合、現実世界のヘルスケアデータへのアクセスと分析方法に関する知識を提供しています。市場が成長するにつれ、競争がイノベーションを促し、より高度なRWE技術やテクノロジーの創出につながります。各社は、がんや希少疾患など特定の治療領域向けにカスタマイズされたソリューションを提供したり、ヘルスケア利害関係者と協力して医療政策、投薬開発、治療最適化におけるRWEの導入を促したりすることで、差別化を図っています。

目次

第1章 現実世界の証拠ソリューション市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 現実世界の証拠ソリューションの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 現実世界の証拠ソリューション業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 現実世界の証拠ソリューション市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 現実世界の証拠ソリューション市場情勢

  • 実世界の証拠ソリューション市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 現実世界の証拠ソリューション市場- コンポーネント別

  • 概要
    • コンポーネント別のセグメントシェア分析
    • データセット
    • コンサルティングと分析

第8章 現実世界のエビデンスソリューション市場- 治療分野別

  • 概要
    • 疾患領域別のセグメントシェア分析
    • 腫瘍学
    • 心臓血管
    • 神経内科
    • 免疫学
    • その他

第9章 現実世界の証拠ソリューション市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 製薬会社および医療機器会社
    • ヘルスケア提供者
    • ヘルスケア支払者
    • その他

第10章 現実世界の証拠ソリューション市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 現実世界の証拠ソリューション業界

  • 競合ダッシュボード
  • 企業プロファイル
    • CLARIVATE PLC
    • Clinigen Group plc
    • Cognizant Technology Solutions Corporation
    • Flatiron Health Inc.
    • IBM Corporation
    • ICON plc
    • IQVIA Holdings Inc.
    • Medpace Holdings Inc.
    • Oracle Corporation
    • PAREXEL International Corporation
    • PerkinElmer Inc.
    • PPD Inc.
    • SAS Institute Inc.
    • Symphony Innovation LLC
    • SYNEOS HEALTH Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Real World Evidence Solutions Market: Component Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Real World Evidence Solutions Market, by Component 2018-2030 (USD Million)
  • TABLE Real World Evidence Solutions Market: Therapeutic Areas Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Real World Evidence Solutions Market, by Therapeutic Areas 2018-2030 (USD Million)
  • TABLE Real World Evidence Solutions Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Real World Evidence Solutions Market, by End-User 2018-2030 (USD Million)
  • TABLE Real World Evidence Solutions Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Real World Evidence Solutions Market, by Region 2018-2030 (USD Million)
  • TABLE North America Real World Evidence Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
  • TABLE North America Real World Evidence Solutions Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE North America Real World Evidence Solutions Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Real World Evidence Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
  • TABLE Europe Real World Evidence Solutions Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Europe Real World Evidence Solutions Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Real World Evidence Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
  • TABLE Asia Pacific Real World Evidence Solutions Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Asia Pacific Real World Evidence Solutions Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Real World Evidence Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
  • TABLE Latin America Real World Evidence Solutions Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Latin America Real World Evidence Solutions Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Real World Evidence Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Real World Evidence Solutions Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Real World Evidence Solutions Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Real World Evidence Solutions Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Component segment market share analysis, 2022 & 2030
  • FIGURE Component segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapeutic Areas segment market share analysis, 2022 & 2030
  • FIGURE Therapeutic Areas segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Real World Evidence Solutions Market share and leading players, 2022
  • FIGURE Europe Real World Evidence Solutions Market share and leading players, 2022
  • FIGURE Asia Pacific Real World Evidence Solutions Market share and leading players, 2022
  • FIGURE Latin America Real World Evidence Solutions Market share and leading players, 2022
  • FIGURE Middle East and Africa Real World Evidence Solutions Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Real World Evidence Solutions Market share analysis by country, 2022
  • FIGURE Germany Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Real World Evidence Solutions Market share analysis by country, 2022
  • FIGURE India Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Real World Evidence Solutions Market share analysis by country, 2022
  • FIGURE Brazil Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Real World Evidence Solutions Market share analysis by country, 2022
  • FIGURE Saudi Arabia Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Real World Evidence Solutions Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1620

REPORT HIGHLIGHT

Real World Evidence Solutions Market size was valued at USD 2,408.1 Million in 2022, expanding at a CAGR of 8.4% from 2023 to 2030.

Methodologies and techniques for capturing data from real-world healthcare contexts, including patient registries, electronic health records, claims databases, and mobile health apps, are examples of real-world evidence solutions. These solutions seek information on the safety, efficiency, and relative efficacy of healthcare treatments across a variety of patient groups and naturalistic settings. Stakeholders in the healthcare ecosystem may acquire significant insights into treatment results, illness development, patient behaviors, and health finances by analyzing large-scale, real-world data. This evidence supplements standard clinical trial data, allowing for more informed decision-making, better patient outcomes, and the creation of evidence-based healthcare policies and treatments that take into account real-world complexity and patient experiences.

Real World Evidence Solutions Market- Market Dynamics:

  • Growing demand for evidence-based decision-making in healthcare to propel market demand.
  • Policymakers, authorities, medical professionals, and pharmaceutical corporations are all aware of the limits of relying simply on conventional clinical trial data, which may not completely represent a treatment's real-world effectiveness and long-term impacts. RWE enables the assessment of therapies in a variety of patient groups while taking into account real-world complexity and differences, resulting in better-informed and nuanced conclusions. Furthermore, the focus on value-based medical and cost-effectiveness drives demand for RWE since it gives critical information into the real-world consequences and economic results of healthcare treatments.

Real World Evidence Solutions Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Real World Evidence Solutions market is estimated to grow annually at a CAGR of around 8.4% over the forecast period (2023-2030)
  • The Real World Evidence Solutions industry is projected to grow at a significant rate due to the growing demand for evidence-based decision-making in healthcare.
  • Based on Component segmentation, Consulting and Analytic was predicted to show maximum market share in the year 2022
  • Based on Therapeutic Areas segmentation, Neurology was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Real World Evidence Solutions Market- Segmentation Analysis:

  • The Global Real World Evidence Solutions Market is segmented on the basis of Component, Therapeutic Areas, End-User, and Region.
  • The market is divided into two categories based on Component: DataSets, Consulting and Analytic. The Consulting and Analytic sector dominates the market. The increased need for Real World Evidence (RWE) solutions has increased the demand for eConsulting and analytics solutions. These services assist stakeholders in successfully accessing, interpreting, and using real-world healthcare data. They allow evidence-based decision-making, improved patient outcomes, and the creation of novel healthcare initiatives by employing sophisticated analytics.
  • The market is divided into five categories based on Therapeutic Areas: Oncology, Cardiovascular, Neurology, Immunology, Others. The Oncology dominates the market and is likely to maintain its dominance during the forecast period. The requirement to understand treatment results, safety, and efficacy in varied cancer patient groups has increased demand for Real World Evidence (RWE) solutions in oncology. Real-world insights supplement clinical trial data, enhancing oncology research, medication development, and personalized treatment methods, eventually improving cancer care.

Real World Evidence Solutions Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several reasons have contributed to a large increase in demand for Real World Evidence (RWE) solutions in the Asia Pacific area. With such a varied and huge population, there is an urgent need to understand the real-world effect of treatment results and healthcare initiatives in this area. RWE empowers healthcare partners in the Asia Pacific to make educated choices, implement evidence-based policies, and successfully optimize healthcare resources. Furthermore, the growing use of digital health technology and electronic health records in many nations around the region has made data collecting for RWE research easier. As a consequence, RWE solutions are critical to expanding medical care and increasing patient results across Asia Pacific.

Real World Evidence Solutions Market- Competitive Landscape:

Because of the increased need for evidence-based decision-making in healthcare, the competitive environment for Real World Evidence (RWE) solutions has been quickly expanding. Several businesses and research organizations are joining this market to provide full RWE services. They provide sophisticated analytics, data integration, and knowledge of how to access and analyze real-world healthcare data. As the market grows, competition encourages innovation, which leads to the creation of more advanced RWE techniques and technology. Companies are attempting to distinguish themselves by offering customized solutions for certain therapeutic areas such as cancer or rare illnesses, as well as by collaborating with healthcare stakeholders to encourage the implementation of RWE in healthcare policy, medication development, and treatment optimization.

Recent Developments:

In June 2023, Verana Health, a digital health firm that improves the quality of real-world data (RWD), has launched VeraSite, a system for discovering possible clinical trial locations. The newly launched subscription-based service allows clinical trial sponsors and contractual research organizations (CROs) to swiftly locate practices with clinical knowledge and prospective patient demographics that are matched to specific study protocols. This data may be used to inform site selection, ensuring that sponsors and CROs pick venues that are more aligned with research objectives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET KEY PLAYERS

  • CLARIVATE PLC
  • Clinigen Group plc
  • Cognizant Technology Solutions Corporation
  • Flatiron Health Inc.
  • IBM Corporation
  • ICON plc
  • IQVIA Holdings Inc.
  • Medpace Holdings Inc.
  • Oracle Corporation
  • PAREXEL International Corporation
  • PerkinElmer Inc.
  • PPD Inc.
  • SAS Institute Inc.
  • Symphony Innovation LLC
  • SYNEOS HEALTH Inc.

GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT

  • DataSets
  • Consulting and Analytic

GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY THERAPEUTIC AREAS

  • Oncology
  • Cardiovascular
  • Neurology
  • Immunology
  • Others

GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END-USER

  • Pharmaceutical and Medical Devices Companies
  • Healthcare Providers
  • Healthcare Payers
  • Others

GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Real World Evidence Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Real World Evidence Solutions Market Snippet by Component
    • 2.1.2. Real World Evidence Solutions Market Snippet by Therapeutic Areas
    • 2.1.3. Real World Evidence Solutions Market Snippet by End-User
    • 2.1.4. Real World Evidence Solutions Market Snippet by Country
    • 2.1.5. Real World Evidence Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Real World Evidence Solutions Key Market Trends

  • 3.1. Real World Evidence Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Real World Evidence Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Real World Evidence Solutions Market Opportunities
  • 3.4. Real World Evidence Solutions Market Future Trends

4. Real World Evidence Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Real World Evidence Solutions Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Real World Evidence Solutions Market Landscape

  • 6.1. Real World Evidence Solutions Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Real World Evidence Solutions Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
    • 7.1.2. DataSets
    • 7.1.3. Consulting and Analytic

8. Real World Evidence Solutions Market - By Therapeutic Areas

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Areas, 2022 & 2030 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiovascular
    • 8.1.4. Neurology
    • 8.1.5. Immunology
    • 8.1.6. Others

9. Real World Evidence Solutions Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical and Medical Devices Companies
    • 9.1.3. Healthcare Providers
    • 9.1.4. Healthcare Payers
    • 9.1.5. Others

10. Real World Evidence Solutions Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Real World Evidence Solutions Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Real World Evidence Solutions Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Real World Evidence Solutions Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Real World Evidence Solutions Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Real World Evidence Solutions Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Real World Evidence Solutions Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. CLARIVATE PLC
    • 11.2.2. Clinigen Group plc
    • 11.2.3. Cognizant Technology Solutions Corporation
    • 11.2.4. Flatiron Health Inc.
    • 11.2.5. IBM Corporation
    • 11.2.6. ICON plc
    • 11.2.7. IQVIA Holdings Inc.
    • 11.2.8. Medpace Holdings Inc.
    • 11.2.9. Oracle Corporation
    • 11.2.10. PAREXEL International Corporation
    • 11.2.11. PerkinElmer Inc.
    • 11.2.12. PPD Inc.
    • 11.2.13. SAS Institute Inc.
    • 11.2.14. Symphony Innovation LLC
    • 11.2.15. SYNEOS HEALTH Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us